Clari Vest Asset Management LLC Clovis Oncology, Inc. Transaction History

Clari Vest Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 07, 2018	SELL	$29.37 - $49.48 $390,650 - $658,133	-13,301 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$42.06 - $62.4 $25,446 - $37,752	-605 Reduced 4.35%	13,301 $605,000
Q1 2018 May 08, 2018	BUY	$50.12 - $67.72 $5,012 - $6,772	100 Added 0.72%	13,906 $734,000
Q4 2017 Feb 13, 2018	SELL	$57.69 - $84.58 $56,478 - $82,803	-979 Reduced 6.62%	13,806 $939,000
Q2 2017 Nov 20, 2017	BUY	N/A	14,785	14,785 $1.38 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.